Novartis (Rights for Ophthalmology Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Novartis (Rights for Ophthalmology Products) General Information

Description

The rights to four ophthalmology products. The rights involve indications for the treatment of glaucoma, allergic conjunctivitis and inflammatory conditions of the eye, in certain European countries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Switzerland
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Rights for Ophthalmology Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Rights for Ophthalmology Products)‘s full profile, request access.

Request a free trial

Novartis (Rights for Ophthalmology Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Rights for Ophthalmology Products)‘s full profile, request access.

Request a free trial

Novartis (Rights for Ophthalmology Products) FAQs

  • Where is Novartis (Rights for Ophthalmology Products) headquartered?

    Novartis (Rights for Ophthalmology Products) is headquartered in Switzerland.

  • What industry is Novartis (Rights for Ophthalmology Products) in?

    Novartis (Rights for Ophthalmology Products)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Novartis (Rights for Ophthalmology Products) a private or public company?

    Novartis (Rights for Ophthalmology Products) is a Private company.

  • What is Novartis (Rights for Ophthalmology Products)’s current revenue?

    The current revenue for Novartis (Rights for Ophthalmology Products) is .

  • Who are Novartis (Rights for Ophthalmology Products)’s investors?

    Novartis has invested in Novartis (Rights for Ophthalmology Products).

  • When was Novartis (Rights for Ophthalmology Products) acquired?

    Novartis (Rights for Ophthalmology Products) was acquired on 01-Oct-2019.

  • Who acquired Novartis (Rights for Ophthalmology Products)?

    Novartis (Rights for Ophthalmology Products) was acquired by Immedica Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process